Search Results
Nov 17, 2025, 11:49 ET ANS abre consulta pública para decidir sobre a inclusão de novo medicamento para dermatite atópica
[19] Ultsch M, et al. Structural basis of signaling blockade by anti-IL-13 antibody Lebrikizumab. J Mol Biol. 2013;425(8):1330-1339. doi:10.1016/j.jmb.2013.01.024 [20] Bieber T. Interleukin-13: Targeting an
More news about: Eli Lilly do Brasil
Nov 07, 2025, 09:00 ET Long-Term Study Reports Sustained Quality of Life Benefits with the BioProtect Balloon Spacer in Prostate Cancer Radiation Therapy
quality of life after prostate IMRT with or without biodegradable balloon rectal spacer: analysis of a pivotal randomized trial.Int J Radiat Oncol Biol Phys. 2025; S0360-3016(25)01710-9.
More news about: BioProtect
Nov 06, 2025, 19:00 ET 里程碑突破！全球首個APOC3基因編輯臨床治療高血脂獲得成功
正序生物CS-121注射液是利用上海科技大學自主研發的高精准變形式鹼基編輯器tBE（transformer Base Editor）（Wang et al.，Nat Cell Biol，2021）開發的針對高乳糜微粒血症/高甘油三酯血症的首款體內基因編輯藥物。tBE由脂質納米粒（Lipid Nanoparticle，LNP）包裝，通過靜脈注射給藥遞送至患者肝臟，對靶標基因APOC3進行精准鹼基編輯，模擬天然APOC3功能缺失人群中的有益突變，下調APOC3的
More news about: CorrectSequence Therapeutics
Oct 24, 2025, 06:45 ET Lilly's EBGLYSS (lebrikizumab-lbkz) delivered durable disease control when administered once every eight weeks in patients with moderate-to-severe atopic dermatitis
doi:10.1007/s13555-023-00947-7. Ultsch M, et al. Structural basis of signaling blockade by anti-IL-13 antibody Lebrikizumab. J Mol Biol. 2013;425(8):1330-1339. doi:10.10116/j.jmb.2013.01.024. Bieber T. Interleukin-13: Targeting an underestimated cytokine in
More news about: Eli Lilly and Company
Oct 21, 2025, 14:33 ET Researchers Link Orphan Gene in SARS-CoV-2 Virus to More Severe Cases of COVID-19
"Importance of de novo gene evolution to emerging viral threats: the ORF10 strain-restricted orphan gene of SARS-CoV-2 promotes pathogenesis." Mol Biol Evol. Online October 1, 2025. DOI: 10.1093/molbev/msaf211. About Children's Hospital of Philadelphia:
More news about: Children's Hospital of Philadelphia
Oct 20, 2025, 06:30 ET IDEAYA Biosciences Announces Positive Phase 2 Data for Darovasertib in the Neoadjuvant Setting of Primary Uveal Melanoma in a Proffered Paper Oral Presentation at ESMO 2025
radiation to the tumor apex is associated with improved visual outcomes (Perez et al, Int J Radiat Oncol Biol Phys. 2014; Kheir et al, Adv Radiat Oncol. 2022; Saconn et al, Int J Radiat Oncol Biol Phys. 2010; Puusaari et al, Invest Ophthalmol Vis Sci. 2004).64.9% (24/37) of the evaluable patients
More news about: IDEAYA Biosciences, Inc.
Oct 13, 2025, 06:45 ET Lilly to present new clinical data for Verzenio (abemaciclib) and multiple novel pipeline programs at the 2025 European Society for Medical Oncology (ESMO) Annual Meeting
inhibitor. Cancer Research. 2021;81(13_Supplement):1259-1259. doi:10.1158/1538-7445.am2021-1259 Dirican E, et al. Tumor Biol. 2016;37(6):7033-7045. Martinez-Saez O, et al. Breast Cancer Res. 2020;22(1):45. First-in-Human
More news about: Eli Lilly and Company
Oct 09, 2025, 08:22 ET Phase 3 Clinical Trial of HANSIZHUANG Plus Chemotherapy Meets Primary Endpoint in Neoadjuvant/Adjuvant Gastric Cancer, Greenlighting Early NDA Submission
[5] Patsoukis N, et al. Interaction of SHP-2 SH2 domains with PD-1 ITSM induces PD-1 dimerization and SHP-2 activation. Commun Biol. 2020;3(1):128.
More news about: Henlius
Oct 09, 2025, 07:38 ET 開創無化療時代：全球首個H藥胃癌圍手術期III期臨床研究達到主要終點，支持提前申報上市
[5] Patsoukis N, et al. Interaction of SHP-2 SH2 domains with PD-1 ITSM induces PD-1 dimerization and SHP-2 activation. Commun Biol. 2020;3(1):128.
More news about: 復宏漢霖
Oct 01, 2025, 11:04 ET BioMarin apresenta novos dados que reforçam sua liderança em saúde óssea na reunião anual da Sociedade Americana de Pesquisa Óssea e Mineral
sciencedirect.com/science/article/pii/S875632822100034X?via%3Dihub Published February 3, 2021. 3 Ornitz DM, Itoh N. The Fibroblast Growth Factor signaling pathway. Wiley Interdiscip Rev Dev Biol. 2015 May-Jun;4(3):215-66. doi: 10.1002/wdev.176. Epub 2015 Mar 13. PMID: 25772309; PMCID: PMC4393358. 4 About Achondroplasia. Genome.gov.
More news about: BioMarin
Sep 30, 2025, 09:22 ET ROVENSA NEXT PRESENTA "BIOSOLUTIONIZE AGRICULTURE"
El portfolio de biosoluciones de Rovensa Next, el m á s completo en la industria, combina productos biol ó gicos y de origen natural con tecnolog í as
More news about: Rovensa Next
Sep 25, 2025, 08:00 ET Introducing SwimClub™: The First Clinically-Formulated Male Fertility Supplement
TG, et al. J Clin Endocrinol Metab. 2020.Martin JA, et al. National Vital Statistics Reports. 2019.Safarinejad MR. Biol Trace Elem Res. 2011.Aksoy Y, et al. Andrologia. 2018.Showell MG, et al. Cochrane Database Syst Rev. 2019.Safarinejad
More news about: Squared Circles